HK Stock MarketDetailed Quotes

03869 HOSPITAL CORP

Watchlist
  • 6.400
  • 0.0000.00%
Not Open Apr 25 16:09 CST
884.44MMarket Cap6.10P/E (TTM)

HOSPITAL CORP Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(Q6)Jun 30, 2019
Turnover
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
-2.84%399.21M
-13.36%180.68M
7.11%410.88M
19.53%208.53M
Operating income
24.92%1.43B
32.71%717.83M
119.68%1.14B
161.00%540.92M
30.33%520.29M
14.71%207.25M
-2.84%399.21M
-13.36%180.68M
7.11%410.88M
19.53%208.53M
Cost of sales
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
13.56%-204.89M
19.43%-99.98M
-2.39%-237.02M
-2.88%-124.09M
Operating expenses
-19.79%-1.19B
-27.50%-597.68M
-224.14%-992.07M
-334.04%-468.76M
-49.38%-306.06M
-8.03%-108M
13.56%-204.89M
19.43%-99.98M
-2.39%-237.02M
-2.88%-124.09M
Gross profit
58.64%239.36M
66.52%120.15M
-29.57%150.88M
-27.30%72.16M
10.24%214.23M
22.98%99.25M
11.77%194.33M
-4.43%80.7M
14.29%173.87M
56.82%84.44M
Selling expenses
-355.81%-1.57M
-123.76%-631K
82.85%-344K
66.39%-282K
-50,050.00%-2.01M
---839K
55.56%-4K
----
95.59%-9K
----
Administrative expenses
-35.81%-129.23M
-39.51%-49.2M
0.74%-95.16M
-67.48%-35.27M
-84.73%-95.87M
28.64%-21.06M
19.58%-51.9M
12.50%-29.51M
-1.92%-64.54M
-3.05%-33.72M
Impairment and provision
100.19%884K
----
20.11%-462.15M
15.76%-460.95M
15.34%-578.46M
18.57%-547.2M
-43,119.23%-683.3M
---671.97M
---1.58M
----
-Impairment of intangible assets
----
----
16.61%-460.28M
15.19%-460.28M
17.40%-551.98M
18.78%-542.72M
---668.22M
---668.22M
----
----
-Other impairment is provision
147.35%884K
----
92.95%-1.87M
85.23%-662K
-75.61%-26.48M
-19.42%-4.48M
-853.64%-15.08M
---3.75M
---1.58M
----
Special items of operating profit
180.06%105.05M
516.00%129.91M
-585.35%-131.21M
-123.26%-31.23M
-80.83%27.04M
-258.31%-13.99M
103.53%141.03M
-79.50%8.84M
226.53%69.29M
208.94%43.09M
Operating profit
139.87%214.5M
143.95%200.23M
-23.65%-537.99M
5.84%-455.57M
-8.81%-435.07M
20.93%-483.84M
-325.86%-399.84M
-752.29%-611.94M
423.07%177.03M
606.07%93.82M
Financing income
-32.71%9.82M
-46.13%4.36M
116.83%14.6M
118.99%8.09M
-63.45%6.73M
-82.50%3.7M
-56.25%18.42M
-16.34%21.12M
1,508.17%42.1M
5,868.32%25.25M
Financing cost
12.13%-8.12M
11.42%-3.62M
55.50%-9.24M
68.21%-4.09M
61.84%-20.76M
-15.95%-12.86M
-130.83%-54.4M
-81.22%-11.09M
-26.85%-23.57M
29.10%-6.12M
Earning before tax
140.59%216.2M
144.51%200.97M
-18.60%-532.63M
8.41%-451.56M
-3.05%-449.1M
18.09%-493M
-322.85%-435.82M
-632.95%-601.91M
993.59%195.57M
522.20%112.94M
Tax
-1,287.30%-47.86M
-261.57%-23.06M
-95.35%4.03M
-82.72%14.27M
487.68%86.71M
136.47%82.58M
156.49%14.75M
293.86%34.92M
36.76%-26.12M
-91.11%-18.01M
After-tax profit from continuing operations
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
-348.50%-421.07M
-697.31%-566.99M
823.48%169.45M
362.40%94.93M
Earning after tax
131.85%168.34M
140.69%177.92M
-45.86%-528.6M
-6.55%-437.29M
13.93%-362.4M
27.61%-410.42M
-348.50%-421.07M
-697.31%-566.99M
823.48%169.45M
362.40%94.93M
Minority profit
177.57%36.96M
----
41.67%-47.65M
----
-388.35%-81.69M
-119.44%-69.32M
-190.19%-16.73M
-344.95%-31.59M
-31.49%18.55M
516.15%12.9M
Profit attributable to shareholders
127.32%131.38M
140.69%177.92M
-71.33%-480.95M
-28.20%-437.29M
30.58%-280.71M
36.29%-341.1M
-367.95%-404.34M
-752.70%-535.4M
398.87%150.9M
314.35%82.03M
Basic earnings per share
127.47%0.956
129.45%0.91
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
-367.95%-2.926
-751.52%-3.87
396.74%1.092
312.14%0.594
Diluted earnings per share
106.12%0.213
99.35%-0.02
-71.34%-3.48
-25.10%-3.09
30.59%-2.031
36.18%-2.47
-1,383.33%-2.926
-77,500.00%-3.87
161.96%0.228
101.79%0.005
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
KPMG
--
KPMG
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
PricewaterhouseCoopers
--
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(Q6)Jun 30, 2019
Turnover 24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M-2.84%399.21M-13.36%180.68M7.11%410.88M19.53%208.53M
Operating income 24.92%1.43B32.71%717.83M119.68%1.14B161.00%540.92M30.33%520.29M14.71%207.25M-2.84%399.21M-13.36%180.68M7.11%410.88M19.53%208.53M
Cost of sales -19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M13.56%-204.89M19.43%-99.98M-2.39%-237.02M-2.88%-124.09M
Operating expenses -19.79%-1.19B-27.50%-597.68M-224.14%-992.07M-334.04%-468.76M-49.38%-306.06M-8.03%-108M13.56%-204.89M19.43%-99.98M-2.39%-237.02M-2.88%-124.09M
Gross profit 58.64%239.36M66.52%120.15M-29.57%150.88M-27.30%72.16M10.24%214.23M22.98%99.25M11.77%194.33M-4.43%80.7M14.29%173.87M56.82%84.44M
Selling expenses -355.81%-1.57M-123.76%-631K82.85%-344K66.39%-282K-50,050.00%-2.01M---839K55.56%-4K----95.59%-9K----
Administrative expenses -35.81%-129.23M-39.51%-49.2M0.74%-95.16M-67.48%-35.27M-84.73%-95.87M28.64%-21.06M19.58%-51.9M12.50%-29.51M-1.92%-64.54M-3.05%-33.72M
Impairment and provision 100.19%884K----20.11%-462.15M15.76%-460.95M15.34%-578.46M18.57%-547.2M-43,119.23%-683.3M---671.97M---1.58M----
-Impairment of intangible assets --------16.61%-460.28M15.19%-460.28M17.40%-551.98M18.78%-542.72M---668.22M---668.22M--------
-Other impairment is provision 147.35%884K----92.95%-1.87M85.23%-662K-75.61%-26.48M-19.42%-4.48M-853.64%-15.08M---3.75M---1.58M----
Special items of operating profit 180.06%105.05M516.00%129.91M-585.35%-131.21M-123.26%-31.23M-80.83%27.04M-258.31%-13.99M103.53%141.03M-79.50%8.84M226.53%69.29M208.94%43.09M
Operating profit 139.87%214.5M143.95%200.23M-23.65%-537.99M5.84%-455.57M-8.81%-435.07M20.93%-483.84M-325.86%-399.84M-752.29%-611.94M423.07%177.03M606.07%93.82M
Financing income -32.71%9.82M-46.13%4.36M116.83%14.6M118.99%8.09M-63.45%6.73M-82.50%3.7M-56.25%18.42M-16.34%21.12M1,508.17%42.1M5,868.32%25.25M
Financing cost 12.13%-8.12M11.42%-3.62M55.50%-9.24M68.21%-4.09M61.84%-20.76M-15.95%-12.86M-130.83%-54.4M-81.22%-11.09M-26.85%-23.57M29.10%-6.12M
Earning before tax 140.59%216.2M144.51%200.97M-18.60%-532.63M8.41%-451.56M-3.05%-449.1M18.09%-493M-322.85%-435.82M-632.95%-601.91M993.59%195.57M522.20%112.94M
Tax -1,287.30%-47.86M-261.57%-23.06M-95.35%4.03M-82.72%14.27M487.68%86.71M136.47%82.58M156.49%14.75M293.86%34.92M36.76%-26.12M-91.11%-18.01M
After-tax profit from continuing operations 131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M-348.50%-421.07M-697.31%-566.99M823.48%169.45M362.40%94.93M
Earning after tax 131.85%168.34M140.69%177.92M-45.86%-528.6M-6.55%-437.29M13.93%-362.4M27.61%-410.42M-348.50%-421.07M-697.31%-566.99M823.48%169.45M362.40%94.93M
Minority profit 177.57%36.96M----41.67%-47.65M-----388.35%-81.69M-119.44%-69.32M-190.19%-16.73M-344.95%-31.59M-31.49%18.55M516.15%12.9M
Profit attributable to shareholders 127.32%131.38M140.69%177.92M-71.33%-480.95M-28.20%-437.29M30.58%-280.71M36.29%-341.1M-367.95%-404.34M-752.70%-535.4M398.87%150.9M314.35%82.03M
Basic earnings per share 127.47%0.956129.45%0.91-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47-367.95%-2.926-751.52%-3.87396.74%1.092312.14%0.594
Diluted earnings per share 106.12%0.21399.35%-0.02-71.34%-3.48-25.10%-3.0930.59%-2.03136.18%-2.47-1,383.33%-2.926-77,500.00%-3.87161.96%0.228101.79%0.005
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor KPMG--KPMG--PricewaterhouseCoopers--PricewaterhouseCoopers--PricewaterhouseCoopers--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg